Innovative Immunotherapy Solutions for Human Diseases
Discover non-canonical surface antigens for enhanced treatment options.
Targeted T Cell
Learn how our MHC SNAP discovery platform enhances immune visibility.
Transforming treatment through innovative research.
Advancing immunology for creating more efficacious therapeutics.
Research Focus
Our Approach
TM
Innovating Cancer Immunotherapy Solutions
At Otter Bio, we focus on discovering novel antigens to amplify cancer visibility, revolutionizing cancer treatment through advanced immunology.
Not just another MHC class I peptide predictor. Redefining new T cell epitopes based on temporal stability
A fragmentable major histocompatibility complex class I (MHC-I) protein system that mimics the endo-lysosomal conditions. A cell-free technology that rapidly prioritises stabilising peptide ligands for CD8+ T cell epitope discovery.
Shorten Clinical Development with Greater Confidence
You didn’t come this far to stop
